RT Journal Article
SR Electronic
T1 Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12–15 years
JF Archives of Disease in Childhood
JO Arch Dis Child
FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
SP 205
OP 207
DO 10.1136/archdischild-2021-322655
VO 107
IS 2
A1 King, Hayley
A1 Deshpande, Sanjay
A1 Woodbridge, Tamsin
A1 Hilliard, Tom
A1 Standing, Jon
A1 Lewis, Mary
A1 Ward, Lesley
A1 Finn, Adam
A1 Roderick, Marion
YR 2022
UL http://adc.bmj.com/content/107/2/205.abstract
AB